Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,894 | 371 | 98.8% |
| Education | $56.99 | 4 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $945.96 | 72 | $0 (2024) |
| Amgen Inc. | $648.00 | 45 | $0 (2024) |
| PFIZER INC. | $369.59 | 29 | $0 (2024) |
| Abbott Laboratories | $358.96 | 39 | $0 (2024) |
| GlaxoSmithKline, LLC. | $284.83 | 19 | $0 (2024) |
| Allergan, Inc. | $276.37 | 23 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $248.26 | 18 | $0 (2024) |
| Novo Nordisk Inc | $248.23 | 19 | $0 (2024) |
| Daiichi Sankyo Inc. | $244.68 | 16 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $198.96 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,268 | 96 | ABBVIE INC. ($331.14) |
| 2023 | $668.59 | 60 | AbbVie Inc. ($190.96) |
| 2022 | $566.36 | 39 | ABBVIE INC. ($173.86) |
| 2021 | $1,026 | 76 | AbbVie Inc. ($217.70) |
| 2020 | $371.91 | 30 | Allergan, Inc. ($160.62) |
| 2019 | $423.89 | 30 | Amgen Inc. ($119.23) |
| 2018 | $489.55 | 35 | Amgen Inc. ($168.80) |
| 2017 | $136.24 | 9 | Allergan Inc. ($41.55) |
All Payment Transactions
375 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Diabetes Care | ||||||
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: UROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: UROLOGY | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: VACCINES | ||||||
| 11/11/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Obesity | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: UROLOGY | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: PAIN | ||||||
| 10/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Bone Health | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: VACCINES | ||||||
| 10/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: Diabetes Care | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: UROLOGY | ||||||
| 09/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: UROLOGY | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 4,603 | 6,427 | $498,174 | $218,786 |
| 2022 | 41 | 5,719 | 10,675 | $656,180 | $294,701 |
| 2021 | 48 | 6,947 | 15,015 | $845,656 | $366,517 |
| 2020 | 39 | 5,851 | 13,051 | $794,610 | $304,672 |
All Medicare Procedures & Services
161 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 511 | 1,036 | $222,740 | $82,516 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 377 | 377 | $65,598 | $45,707 | 69.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 225 | 226 | $25,990 | $16,236 | 62.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 434 | 610 | $29,280 | $10,041 | 34.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 463 | 691 | $28,331 | $9,056 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 68 | $19,040 | $8,173 | 42.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 499 | 932 | $9,320 | $7,814 | 83.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 232 | 233 | $8,621 | $6,957 | 80.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 397 | 508 | $12,192 | $4,211 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 78 | $11,700 | $3,999 | 34.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $7,449 | $3,658 | 49.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 300 | 323 | $10,336 | $3,343 | 32.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 138 | 235 | $7,050 | $2,237 | 31.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 69 | 76 | $6,232 | $2,205 | 35.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 228 | 275 | $6,600 | $2,093 | 31.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 151 | 234 | $6,084 | $2,069 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,809 | $1,545 | 40.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 71 | 79 | $3,397 | $1,168 | 34.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 25 | 26 | $2,548 | $1,007 | 39.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 43 | 43 | $2,236 | $813.56 | 36.4% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 20 | 20 | $1,160 | $796.32 | 68.6% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 15 | 19 | $1,786 | $730.93 | 40.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 37 | 37 | $999.00 | $624.93 | 62.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 42 | $1,764 | $386.65 | 21.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $516.00 | $359.28 | 69.6% |
About Dr. Indumathi Baskar, M.D
Dr. Indumathi Baskar, M.D is a Internal Medicine healthcare provider based in Jefferson City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083634331.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Indumathi Baskar, M.D has received a total of $4,951 in payments from pharmaceutical and medical device companies, with $1,268 received in 2024. These payments were reported across 375 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,894).
As a Medicare-enrolled provider, Baskar has provided services to 23,120 Medicare beneficiaries, totaling 45,168 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 161 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Jefferson City, MO
- Active Since 07/20/2006
- Last Updated 10/18/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083634331
Products in Payments
- UBRELVY (Drug) $633.02
- NURTEC ODT (Drug) $292.62
- GEMTESA (Drug) $270.39
- SHINGRIX (Biological) $268.39
- QULIPTA (Drug) $247.35
- INJECTAFER (Drug) $244.68
- EVENITY (Biological) $228.05
- Aimovig (Biological) $218.50
- FREESTYLE LIBRE 3 (Device) $186.20
- FREESTYLE LIBRE 2 (Device) $172.76
- FARXIGA (Drug) $159.13
- Ozempic (Drug) $143.42
- VRAYLAR (Drug) $137.57
- Prolia (Biological) $96.50
- LINZESS (Drug) $90.79
- Kerendia (Drug) $78.58
- BYSTOLIC (Drug) $76.49
- ENTRESTO (Drug) $76.07
- Otezla (Drug) $74.15
- XARELTO (Drug) $70.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jefferson City
Dr. Alan Rauba, M.d, M.D
Internal Medicine — Payments: $921,314
Dr. Christopher Case, M.d, M.D
Internal Medicine — Payments: $193,448
Dr. Thomas Schneider, M.d, M.D
Internal Medicine — Payments: $17,202
Dr. Stephen Sides, D.o, D.O
Internal Medicine — Payments: $11,660
Lorenzo Mcknelly, D.o, D.O
Internal Medicine — Payments: $10,588
John Kirby, M.d, M.D
Internal Medicine — Payments: $7,872